{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:30:14Z","timestamp":1762821014719,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jacbts.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T14:00:03Z","timestamp":1693231203000},"page":"1008-1009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["INKing the Cardiotoxicity Out\u00a0of\u00a0Doxorubicin"],"prefix":"10.1016","volume":"8","author":[{"given":"Zhen","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Javaheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2023.05.001_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jacbts.2023.05.001_bib2","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1177\/2047487319901208","article-title":"Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice","volume":"27","author":"Obata","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacbts.2023.05.001_bib3","first-page":"992","article-title":"IFN-\u03b3-STAT1-ERK pathway mediates protective effects of invariant natural killer T cells against doxorubicin-induced cardiomyocyte death","volume":"8","author":"Sada","year":"2023","journal-title":"J\u00a0Am Coll Cardiol Basic Trans Science"},{"key":"10.1016\/j.jacbts.2023.05.001_bib4","first-page":"340","article-title":"Apolipoprotein M attenuates anthracycline cardiotoxicity and lysosomal injury","volume":"8","author":"Guo","year":"2023","journal-title":"J\u00a0Am Coll Cardiol Basic Trans Science"},{"issue":"23","key":"10.1016\/j.jacbts.2023.05.001_bib5","first-page":"00042","article-title":"Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity","volume":"S1550-4131","author":"Ozcan","year":"2023","journal-title":"Cell Metab"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X23001997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X23001997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:26:20Z","timestamp":1762820780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X23001997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2452302X23001997"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2023.05.001","relation":{},"ISSN":["2452-302X"],"issn-type":[{"type":"print","value":"2452-302X"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"INKing the Cardiotoxicity Out\u00a0of\u00a0Doxorubicin","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2023.02.014","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the American College of Cardiology Foundation.  .","name":"copyright","label":"Copyright"}]}}